SEC Form 4 · accession 0001127602-17-009986
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nathan Folkert
Officer — VP GM Orthopedics
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 1:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2017 | M | 500 | $0.00 | A | 500 | D | |
| Common Stock | Mar 1, 2017 | F | 164 | $41.93 | D | 336 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rsus (restricted Stock Units)F1 | $0.00 | Mar 1, 2017 | M | 500 | D | — | Mar 1, 2026 | Common Stock | 500 | 1,500 | D |
| Options To Purchase Common StockF2 | $41.93 | Mar 1, 2017 | A | 36,000 | A | — | Mar 1, 2027 | Common Stock | 36,000 | 36,000 | D |
| Rsus (restricted Stock Units)F1 | $0.00 | Mar 1, 2017 | A | 1,600 | A | — | Mar 1, 2027 | Common Stock | 1,600 | 1,600 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
- F2The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period